ACTH Assay
Device
Abbott Laboratories
Total Payments
$193,574
Transactions
2
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $193,574 | 2 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $193,574 | 2 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Comprehensive Evaluation of Acute Effects of Sacubitril Valsartan on Heart Failure Biomarkers | Abbott Laboratories | $193,574 | 0 |
Top Doctors Receiving Payments for ACTH Assay
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Boston, MA | $193,574 | 2 |
Ad
Manufacturing Companies
- Abbott Laboratories $193,574
Product Information
- Type Device
- Total Payments $193,574
- Total Doctors 0
- Transactions 2
About ACTH Assay
ACTH Assay is a device associated with $193,574 in payments to 0 healthcare providers, recorded across 2 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2018 to 2018. In 2018, $193,574 was paid across 2 transactions to 0 doctors.
The most common payment nature for ACTH Assay is "Unspecified" ($193,574, 100.0% of total).
ACTH Assay is associated with 1 research study, including "Comprehensive Evaluation of Acute Effects of Sacubitril Valsartan on Heart Failure Biomarkers" ($193,574).